Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibα

被引:37
作者
Vasudevan, S
Roberts, JR
McClintock, RA
Dent, JA
Celikel, R
Ware, J
Varughese, KI
Ruggeri, ZM
机构
[1] Scripps Res Inst, Res Inst,Dept Mol & Expt Med, Roon Res Ctr Arteriosclerosis & Thrombosis, Div Expt Hemostasis & Thrombosis, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.275.17.12763
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Binding of the von Willebrand factor (vWF) A1 domain to the glycoprotein (GP) Ib-IX-V complex mediates platelet adhesion to reactive substrates under high shear stress conditions, a key event in hemostasis and thrombosis. We have now used the known three-dimensional structure of the A1 domain to model the interaction with the GP Ib alpha sequence 271-279, which has previously been implicated in ligand binding: Docking procedures suggested that A1 domain residues in strand beta 3 and preceding loop (residues 559-566) as well as in helix alpha 3 (residues 594-603) interact with Asp residues 272, 274, 277 and sulfated Tyr residues 278 and 279 in GP Ib alpha. To verify this model, 14 mutant A1 domain fragments containing single or multiple side chain substitutions were tested for their ability to mediate platelet adhesion under flow. Each of the vWF residues Tyr(565), GlU(596), and Lys(599) proved to be strictly required for A1 domain function, which, in agreement with previous findings, was also dependent on Gly(561). Moreover, an accessory functional role was apparent for a group of positively charged residues, including Arg at positions 629, 632, 636 and Lye at positions 643 and 645, possibly acting in concert. There was, however, no evidence from the model that these residues directly participate in forming the complex with GP Ib alpha. These results provide a partial model of the vWF-GP Ib alpha interaction linked to the manifestation of functional activity in platelet adhesion.
引用
收藏
页码:12763 / 12768
页数:6
相关论文
共 45 条
[1]   PURIFICATION OF BOTROCETIN FROM BOTHROPS-JARARACA VENOM - ANALYSIS OF THE BOTROCETIN-MEDIATED INTERACTION BETWEEN VONWILLEBRAND-FACTOR AND THE HUMAN-PLATELET MEMBRANE GLYCOPROTEIN-IB-IX COMPLEX [J].
ANDREWS, RK ;
BOOTH, WJ ;
GORMAN, JJ ;
CASTALDI, PA ;
BERNDT, MC .
BIOCHEMISTRY, 1989, 28 (21) :8317-8326
[2]  
BADIMON L, 1998, VONWILLEBRAND FACTOR, P225
[3]  
BERLINER S, 1988, J BIOL CHEM, V263, P7500
[4]   IDENTIFICATION OF ASPARTIC ACID-514 THROUGH GLUTAMIC ACID-542 AS A GLYCOPROTEIN-IB-IX COMPLEX RECEPTOR RECOGNITION SEQUENCE IN VONWILLEBRAND-FACTOR - MECHANISM OF MODULATION OF VONWILLEBRAND-FACTOR BY RISTOCETIN AND BOTROCETIN [J].
BERNDT, MC ;
WARD, CM ;
BOOTH, WJ ;
CASTALDI, PA ;
MAZUROV, AV ;
ANDREWS, RK .
BIOCHEMISTRY, 1992, 31 (45) :11144-11151
[5]  
BRUNGER AT, 1996, X PLOR CRYSTALLOGRPA
[6]   Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab [J].
Celikel, R ;
Varughese, KI ;
Madhusudan ;
Yoshioka, A ;
Ware, J ;
Ruggeri, ZM .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (03) :189-194
[7]  
CELIKEL R, 1997, BLOOD CELL MOL DIS, V23, P124
[8]  
CLAMP JR, 1971, IMMUNOCHEMISTRY, V8, P871
[9]   ANALYTICAL MOLECULAR-SURFACE CALCULATION [J].
CONNOLLY, ML .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1983, 16 (OCT) :548-558
[10]  
CRUZ MA, 1993, J BIOL CHEM, V268, P21238